pI: 5.0937 |
Length (AA): 777 |
MW (Da): 86859 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 83 | 5ff5 (A) | 127 | 208 | 26.00 | 0.13 | 0.42 | 0.47757 | -0.78 |
4 | 184 | 1jw9 (B) | 28 | 189 | 30.00 | 0 | 1 | 0.445847 | -0.01 |
9 | 613 | 3kyd (B) | 19 | 534 | 50.00 | 0 | 1 | 0.966239 | 0.35 |
9 | 656 | 3kyc (B) | 19 | 635 | 45.00 | 0 | 1 | 1.11695 | 0.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127838)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G21470 | SUMO-activating enzyme subunit 2 |
Babesia bovis | BBOV_IV001050 | ubiquitin-activating enzyme, putative |
Brugia malayi | Bm1_53850 | ThiF family protein |
Candida albicans | CaO19.5074 | similar to Uba1 (Ub-activating enzyme) |
Candida albicans | CaO19.12540 | similar to Uba1 (Ub-activating enzyme) |
Cryptosporidium hominis | Chro.20160 | SUMO-1 activating enzyme subunit 2 |
Cryptosporidium parvum | cgd2_1460 | SUMO-1 activating enzyme subunit 2, putative |
Dictyostelium discoideum | DDB_G0286919 | sumo-activating enzyme subunit 2 |
Drosophila melanogaster | Dmel_CG7528 | Smt3 activating enzyme 2 |
Echinococcus granulosus | EgrG_001145300 | sumo-activating enzyme subunit 2 |
Entamoeba histolytica | EHI_035540 | ubiquitin-activating enzyme, putative |
Echinococcus multilocularis | EmuJ_001145300 | SUMO activating enzyme subunit 2 |
Giardia lamblia | GL50803_6288 | Ubiquitin-activating enzyme E1 1 |
Homo sapiens | ENSG00000126261 | ubiquitin-like modifier activating enzyme 2 |
Leishmania braziliensis | LbrM.08.0230 | ubiquitin-activating enzyme-like protein |
Leishmania donovani | LdBPK_080230.1 | ubiquitin-activating enzyme-like protein |
Leishmania infantum | LinJ.08.0230 | ubiquitin-activating enzyme-like protein |
Leishmania major | LmjF.08.0220 | ubiquitin-activating enzyme-like protein |
Leishmania mexicana | LmxM.08.0220 | ubiquitin-activating enzyme-like protein |
Loa Loa (eye worm) | LOAG_07505 | ThiF family protein |
Mus musculus | ENSMUSG00000052997 | ubiquitin-like modifier activating enzyme 2 |
Neospora caninum | NCLIV_055390 | AFR138Wp, related |
Oryza sativa | 4343750 | Os07g0586500 |
Plasmodium berghei | PBANKA_1451600 | SUMO-activating enzyme subunit 2, putative |
Plasmodium falciparum | PF3D7_1237000 | SUMO-activating enzyme subunit 2 |
Plasmodium knowlesi | PKNH_1456700 | SUMO-activating enzyme subunit 2, putative |
Plasmodium vivax | PVX_100800 | SUMO-activating enzyme subunit 2, putative |
Plasmodium yoelii | PY05539 | related to ubiquitin-activating enzyme homolog UBA2-related |
Saccharomyces cerevisiae | YDR390C | E1 ubiquitin-activating protein UBA2 |
Schistosoma japonicum | Sjp_0101860 | ko:K10685 ubiquitin-like 1-activating enzyme E1 B, putative |
Schistosoma mansoni | Smp_166220 | ubiquitin-activating enzyme E1b |
Schmidtea mediterranea | mk4.026733.00 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.002146.08 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.003668.01 | SUMO-activating enzyme subunit 2 |
Schmidtea mediterranea | mk4.000051.00 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.021673.00 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.015346.00 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.002412.00 | SUMO-activating enzyme subunit uba-2 |
Schmidtea mediterranea | mk4.016507.01 | |
Schmidtea mediterranea | mk4.000092.00 | SUMO-activating enzyme subunit uba-2 |
Trypanosoma brucei gambiense | Tbg972.5.4810 | ubiquitin-activating enzyme e1, putative |
Trypanosoma brucei | Tb927.5.3430 | ubiquitin-activating enzyme E1, putative |
Trypanosoma congolense | TcIL3000_5_3890 | ubiquitin-activating enzyme E1, putative |
Trypanosoma cruzi | TcCLB.509117.10 | ubiquitin-activating enzyme, putative |
Trypanosoma cruzi | TcCLB.511655.69 | ubiquitin-activating enzyme-like protein |
Trypanosoma cruzi | TcCLB.509777.100 | ubiquitin-activating enzyme, putative |
Toxoplasma gondii | TGME49_311500 | ThiF family protein |
Theileria parva | TP01_0127 | ubiquitin-protein ligase, putative |
Trichomonas vaginalis | TVAG_211530 | molybdopterin biosynthesis moeb protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.3430 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.3430 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.3430 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.5.3430 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YDR390C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1451600 | Plasmodium berghei | Essential | plasmo |
TGME49_311500 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ubiquitin-like modifier activating enzyme 2 | Compounds | References |